Galectin-1 Tunes TCR Binding and Signal Transduction to Regulate CD8 Burst Size1

T cell burst size is regulated by the duration of TCR engagement and balanced control of Ag-induced activation, expansion, and apoptosis. We found that galectin-1-deficient CD8 T cells undergo greater cell division in response to TCR stimulation, with fewer dividing cells undergoing apoptosis. TCR-induced ERK signaling was sustained in activated galectin-1-deficient CD8 T cells and antagonized by recombinant galectin-1, indicating galectin-1 modulates TCR feed-forward/feedback loops involved in signal discrimination and procession. Furthermore, recombinant galectin-1 antagonized binding of agonist tetramers to the TCR on activated OT-1 T cells. Finally, galectin-1 produced by activated Ag-specific CD8 T cells negatively regulated burst size and TCR avidity in vivo. Therefore, galectin-1, inducibly expressed by activated CD8 T cells, functions as an autocrine negative regulator of peripheral CD8 T cell TCR binding, signal transduction, and burst size. Together with recent findings demonstrating that gal-1 promotes binding of agonist tetramers to the TCR of OT-1 thymocytes, these studies identify galectin-1 as a tuner of TCR binding, signaling, and functional fate determination that can differentially specify outcome, depending on the developmental and activation stage of the T cell.

[1]  Daniel R. Beisner,et al.  Antigen-mediated T cell expansion regulated by parallel pathways of death , 2008, Proceedings of the National Academy of Sciences.

[2]  Scot D. Liu,et al.  Galectin‐1 functions as a Th2 cytokine that selectively induces Th1 apoptosis and promotes Th2 function , 2008, European journal of immunology.

[3]  P. Courtoy,et al.  Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes. , 2008, Immunity.

[4]  S. Sidhu,et al.  Regulation of a Late Phase of T Cell Polarity and Effector Functions by Crtam , 2008, Cell.

[5]  L. Baum,et al.  Endogenous galectin‐1 enforces class I‐restricted TCR functional fate decisions in thymocytes , 2008, Blood.

[6]  S. Stowell,et al.  Differential Roles of Galectin-1 and Galectin-3 in Regulating Leukocyte Viability and Cytokine Secretion1 , 2008, The Journal of Immunology.

[7]  M. Demetriou,et al.  Lateral Compartmentalization of T Cell Receptor Versus CD45 by Galectin-N-Glycan Binding and Microfilaments Coordinate Basal and Activation Signaling* , 2007, Journal of Biological Chemistry.

[8]  E. Wherry,et al.  Molecular signature of CD8+ T cell exhaustion during chronic viral infection. , 2007, Immunity.

[9]  G. Rabinovich,et al.  An Emerging Role for Galectins in Tuning the Immune Response: Lessons from Experimental Models of Inflammatory Disease, Autoimmunity and Cancer , 2007, Scandinavian journal of immunology.

[10]  J. Correale,et al.  Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death , 2007, Nature Immunology.

[11]  J. Harty,et al.  Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8(+) T cell response to infection. , 2007, Immunity.

[12]  J. Dennis,et al.  Complex N-Glycan Number and Degree of Branching Cooperate to Regulate Cell Proliferation and Differentiation , 2007, Cell.

[13]  John T. Chang,et al.  Asymmetric T Lymphocyte Division in the Initiation of Adaptive Immune Responses , 2007, Science.

[14]  J. Svaren,et al.  Differential requirement for Lck during primary and memory CD8+ T cell responses , 2006, Proceedings of the National Academy of Sciences.

[15]  M. Fukuda,et al.  Galectin-1 Binds Different CD43 Glycoforms to Cluster CD43 and Regulate T Cell Death1 , 2006, The Journal of Immunology.

[16]  M. Bevan,et al.  Duration of the initial TCR stimulus controls the magnitude but not functionality of the CD8+ T cell response , 2006, The Journal of experimental medicine.

[17]  G. Pedraza-Alva,et al.  TCR-Dependent Cell Response Is Modulated by the Timing of CD43 Engagement1 , 2006, The Journal of Immunology.

[18]  Simon C Watkins,et al.  Transgenic Galectin-1 Induces Maturation of Dendritic Cells That Elicit Contrasting Responses in Naive and Activated T Cells1 , 2006, The Journal of Immunology.

[19]  P. Friedl,et al.  Tuning immune responses: diversity and adaptation of the immunological synapse , 2005, Nature Reviews Immunology.

[20]  Min Zhang,et al.  CD45 Signals outside of Lipid Rafts to Promote ERK Activation, Synaptic Raft Clustering, and IL-2 Production1 , 2005, The Journal of Immunology.

[21]  W. Mori,et al.  Simulation of a 50GeV PWFA Stage , 2004 .

[22]  E. Allenspach,et al.  CD43 Regulation of T Cell Activation Is Not through Steric Inhibition of T Cell–APC Interactions but through an Intracellular Mechanism , 2004, The Journal of experimental medicine.

[23]  H. Gabius,et al.  Galectin-3 Precipitates as a Pentamer with Synthetic Multivalent Carbohydrates and Forms Heterogeneous Cross-linked Complexes* , 2004, Journal of Biological Chemistry.

[24]  S. Henrickson,et al.  T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases , 2004, Nature.

[25]  T. Yoshii,et al.  CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. , 2003, Cancer research.

[26]  L. Lefrançois,et al.  Sustained Response Initiation Is Required for T Cell Clonal Expansion But Not for Effector or Memory Development In Vivo 1 , 2003, The Journal of Immunology.

[27]  Stephen P. Schoenberger,et al.  Dynamic programming of CD8+ T lymphocyte responses , 2003, Nature Immunology.

[28]  L. Baum,et al.  The ST6Gal I Sialyltransferase Selectively ModifiesN-Glycans on CD45 to Negatively Regulate Galectin-1-induced CD45 Clustering, Phosphatase Modulation, and T Cell Death* , 2003, The Journal of Biological Chemistry.

[29]  Bernhard Hemmer,et al.  TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways , 2003, Nature Immunology.

[30]  A. Sperling,et al.  The distal pole complex: a novel membrane domain distal to the immunological synapse , 2002, Immunological reviews.

[31]  Y. Kloog,et al.  Galectin-1 Augments Ras Activation and Diverts Ras Signals to Raf-1 at the Expense of Phosphoinositide 3-Kinase* , 2002, The Journal of Biological Chemistry.

[32]  Kristin A. Hogquist,et al.  Sweet 'n' sour: the impact of differential glycosylation on T cell responses , 2002, Nature Immunology.

[33]  L. Baum,et al.  Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions. , 2002, Current opinion in structural biology.

[34]  G. Rabinovich,et al.  Role of galectins in inflammatory and immunomodulatory processes. , 2002, Biochimica et biophysica acta.

[35]  R. Ahmed,et al.  Dynamic Regulation of T Cell Immunity by CD431 , 2002, The Journal of Immunology.

[36]  Stefano Iacobelli,et al.  Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? , 2002, Trends in immunology.

[37]  S. Ugurel,et al.  CD4+CD7− leukemic T cells from patients with Sézary syndrome are protected from galectin-1-triggered T cell death , 2002, Leukemia.

[38]  P. Shrikant,et al.  Activation-Induced Nonresponsiveness: A Th-Dependent Regulatory Checkpoint in the CTL Response1 , 2002, The Journal of Immunology.

[39]  M. Byrne,et al.  CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. , 2002, Immunity.

[40]  L. Baum,et al.  CD45 Modulates Galectin-1-Induced T Cell Death: Regulation by Expression of Core 2 O-Glycans1 , 2001, The Journal of Immunology.

[41]  A. Khoruts,et al.  Homeostatic Expansion Occurs Independently of Costimulatory Signals1 , 2001, The Journal of Immunology.

[42]  Y. Kloog,et al.  Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation , 2001, Oncogene.

[43]  M. Mescher,et al.  Signaling Alterations in Activation-Induced Nonresponsive CD8 T Cells1 , 2001, The Journal of Immunology.

[44]  Susan M. Kaech,et al.  Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells , 2001, Nature Immunology.

[45]  T. Eberlein,et al.  Expression and function of galectin‐3, a β‐galactoside‐binding protein in activated T lymphocytes , 2001, Journal of Leukocyte Biology.

[46]  M. Miceli,et al.  Co-stimulation and counter-stimulation: lipid raft clustering controls TCR signaling and functional outcomes. , 2001, Seminars in immunology.

[47]  J. Lowe.  Glycosylation, Immunity, and Autoimmunity , 2001, Cell.

[48]  M. Davis,et al.  A kinetic window constricts the T cell receptor repertoire in the thymus. , 2001, Immunity.

[49]  J. Dennis,et al.  Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation , 2001, Nature.

[50]  H. Ploegh,et al.  Viral immune evasion strategies and the underlying cell biology. , 2001, Seminars in immunology.

[51]  S. Jameson,et al.  Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo , 2000, Nature Immunology.

[52]  L. A. Lewis,et al.  Galectin-1 Induces Partial TCR ζ-Chain Phosphorylation and Antagonizes Processive TCR Signal Transduction1 , 2000, The Journal of Immunology.

[53]  L. Baum,et al.  Cutting Edge: CD7 Delivers a Pro-Apoptotic Signal During Galectin-1-Induced T Cell Death1 , 2000, The Journal of Immunology.

[54]  R. Ahmed,et al.  Cutting Edge: Naive T Cells Masquerading as Memory Cells , 2000, The Journal of Immunology.

[55]  S. Tsuboi,et al.  Expression of a Specific Glycosyltransferase Enzyme Regulates T Cell Death Mediated by Galectin-1* , 2000, The Journal of Biological Chemistry.

[56]  J. Altman,et al.  Differentiating between Memory and Effector Cd8 T Cells by Altered Expression of Cell Surface O-Glycans , 2000, The Journal of experimental medicine.

[57]  J. Marth,et al.  The ST3Gal-I sialyltransferase controls CD8+ T lymphocyte homeostasis by modulating O-glycan biosynthesis. , 2000, Immunity.

[58]  J. Hirabayashi,et al.  Involvement of CD2 and CD3 in galectin-1 induced signaling in human Jurkat T-cells. , 2000, Glycobiology.

[59]  J. Altman,et al.  Soluble Antigen and CD40 Triggering Are Sufficient to Induce Primary and Memory Cytotoxic T Cells1 , 2000, The Journal of Immunology.

[60]  P. Stewart,et al.  Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1. , 1999, Journal of immunology.

[61]  R. Kedl,et al.  CD8+ T cells become nonresponsive (anergic) following activation in the presence of costimulation. , 1999, Journal of immunology.

[62]  J. Brock,et al.  Galectin-1, a natural ligand for the receptor-type protein tyrosine phosphatase CD45. , 1999, Immunology letters.

[63]  M. Davis,et al.  A kinetic basis for T cell receptor repertoire selection during an immune response. , 1999, Immunity.

[64]  L. A. Lewis,et al.  Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation. , 1999, Journal of immunology.

[65]  Suneet Agarwal,et al.  Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. , 1998, Immunity.

[66]  S Oehen,et al.  Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. , 1998, Journal of immunology.

[67]  R. Ahmed,et al.  Alterations in cell surface carbohydrates on T cells from virally infected mice can distinguish effector/memory CD8+ T cells from naive cells. , 1998, Journal of immunology.

[68]  Hans-Joachim Gabius,et al.  Galectin-1 Is a Major Receptor for Ganglioside GM1, a Product of the Growth-controlling Activity of a Cell Surface Ganglioside Sialidase, on Human Neuroblastoma Cells in Culture* , 1998, The Journal of Biological Chemistry.

[69]  R. Germain,et al.  Selective Induction of Apoptosis in Mature T Lymphocytes by Variant T Cell Receptor Ligands , 1998, The Journal of experimental medicine.

[70]  L. Baum,et al.  Galectin-1, an Endogenous Lectin Produced by Thymic Epithelial Cells, Induces Apoptosis of Human Thymocytes , 1997, The Journal of experimental medicine.

[71]  Susanne Carlsson,et al.  Introduction to galectins , 1997, Glycoconjugate Journal.

[72]  R. Germain,et al.  Partial signaling by CD8+ T cells in response to antagonist ligands , 1996, The Journal of experimental medicine.

[73]  L. Baum,et al.  Apoptosis of T cells mediated by galectin-1 , 1995, Nature.

[74]  L. Samelson,et al.  Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists , 1995, Science.

[75]  D. Loh,et al.  Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. , 1994, Immunity.

[76]  E. Robertson,et al.  Normal development of mice carrying a null mutation in the gene encoding the L14 S-type lectin. , 1993, Development.

[77]  J Hirabayashi,et al.  The family of metazoan metal-independent beta-galactoside-binding lectins: structure, function and molecular evolution. , 1993, Glycobiology.

[78]  P. Allen,et al.  Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells , 1993, Nature.

[79]  J. Mordoh,et al.  Galectin-1 receptors in different cell types. , 2005, Journal of biomedical science.

[80]  L. Baum.  Developing a taste for sweets. , 2002, Immunity.

[81]  C. Fred Brewer.  Binding and cross-linking properties of galectins. , 2002, Biochimica et biophysica acta.

[82]  C. Brewer.  Cutting edge: CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death , 2001 .

[83]  H. Pircher,et al.  Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells. , 1998, European journal of immunology.